
Q-TWiST Analysis to Assess Benefit–Risk of Pembrolizumab in Patients with PD-L1–Positive Advanced or Metastatic Non-small Cell Lung Cancer
Huang, Min, Pietanza, M. Catherine, Samkari, Ayman, Pellissier, James, Burke, Thomas, Chandwani, Sheenu, Kong, Fansen, Pickard, A. SimonLangue:
english
Journal:
PharmacoEconomics
DOI:
10.1007/s40273-018-0752-0
Date:
December, 2018
Fichier:
PDF, 1.29 MB
english, 2018